Skip to main content

Table 2 Age-specific prevalence of high-risk HPV and precancer among women living with HIV (WLWH)

From: Design and feasibility of a novel program of cervical screening in Nigeria: self-sampled HPV testing paired with visual triage

Age at screening (years) No. of women screened in the age group No. of HPV-positive (% of women screened) (95% CI) Colposcopy attendance among HPV-positive Histopathology resultsa (% of women attending colposcopyb) (95% CI) Yield of the screening effortb (% of total women screened)
CIN2+ CIN3+ CIN2+ CIN3+
30–34 77 35 (45.5%) (34.1–57.2%) 27 (77.1%) 1 (3.8%) (0.1–19.6%) 1 (3.8%) (0.1–19.6%) 1.3% 1.3%
35–39 160 57 (35.6%) (28.2–43.6%) 41 (71.9%) 2 (5.0%) (0.6–16.9%) 2 (5.0%) (0.6–16.9%) 1.3% 1.3%
40–44 134 46 (34.3%) (26.3–43.0%) 40 (87.0%) 4 (10.0%) (2.8–23.7%) 3 (7.5%) (1.6–20.4%) 3.0% 2.2%
45–49 71 41 (57.7%) (45.4–69.4%) 35 (85.4%) 4 (11.4%) (3.2–26.7%) 3 (8.6%) (1.8–23.1%) 5.6% 4.2%
Total 442 179 (40.5%) (35.9–45.2%) 143 (79.9%) 11 (7.8%) (4.0–13.5%) 9 (6.4%) (3.0–11.8%) 2.5% 2.0%
  1. aCIN2+ and CIN3+ includes one case of squamous cell carcinoma in a 49-year old woman
  2. bHistopathology report was not completed for two participants due to COVID-19 pandemic spread. These two participants were excluded from the denominator